Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
922
datasets available to search
ShareScore release 0.9.0
Dataset results
922 results for “Chronic lymphocytic leukemia”
Phase I Study of Lenalidomide, Rituximab and Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT02200848. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate VIP152 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia or Richter Syndrome
ClinicalTrials.gov study NCT04978779. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Study of Forodesine Hydrochloride in Patients With Advanced, Fludarabine-refractory Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00289549. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Alvocidib in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT00377104. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Tolerability of XmAb®5574 in Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01161511. IPD Sharing: Not stated. Countries: 1. Publications: 1.
FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00769522. IPD Sharing: NO. Countries: 1. Publications: 6.
Ofatumumab Cardiac Repolarization (QTc) Study in Fludarabine-Refractory Chronic Lymphocytic Leukemia Subjects
ClinicalTrials.gov study NCT01110031. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Determining Clinical Study Experiences of Chronic Lymphocytic Leukemia Patients
ClinicalTrials.gov study NCT05899543. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
HuMax-CD20 in Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00093314. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults with Relapsed/Refractory Large B Cell Lymphoma, Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (ALPHA2)
ClinicalTrials.gov study NCT04416984. IPD Sharing: NO. Countries: 3. Publications: 1.
Phase 2 Study to Assess Activity & Safety of Front-line Ibrutinib + Rituximab in Unfit Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02232386. IPD Sharing: NO. Countries: 1. Publications: 1.
Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia
ClinicalTrials.gov study NCT00281983. IPD Sharing: NO. Countries: 2. Publications: 5.
Combination Chemotherapy With or Without Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00337246. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Compassionate Use of Campath-1H in Treating Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00021151. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Kinetic Biomarker for Chronic Lymphocytic Leukemia Prognosis
ClinicalTrials.gov study NCT00481858. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00262782. IPD Sharing: NO. Countries: 2. Publications: 8.
Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00004218. IPD Sharing: Not stated. Countries: 8. Publications: 7.
Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00275054. IPD Sharing: NO. Countries: 3. Publications: 2.
Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
ClinicalTrials.gov study NCT00466531. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of AMD3100 (Plerixafor) and Rituximab in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT00694590. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.